Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

Valent P, Akin C, Bonadonna P, Hartmann K, Brockow K, Niedoszytko M, Nedoszytko B, Siebenhaar F, Sperr WR, Oude Elberink JNG, Butterfield JH, Alvarez-Twose I, Sotlar K, Reiter A, Kluin-Nelemans HC, Hermine O, Gotlib J, Broesby-Olsen S, Orfao A, Horny HP, Triggiani M, Arock M, Schwartz LB, Metcalfe DD.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1125-1133.e1. doi: 10.1016/j.jaip.2019.01.006. Epub 2019 Feb 5. Review.

PMID:
30737190
2.

Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.

Valent P, Akin C.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1109-1114. doi: 10.1016/j.jaip.2018.11.045. Review.

3.

Mast cell activation syndromes: definition and classification.

Valent P.

Allergy. 2013 Apr;68(4):417-24. doi: 10.1111/all.12126. Epub 2013 Feb 15. Review.

PMID:
23409940
4.

Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, Castells M, Escribano L, Hartmann K, Lieberman P, Nedoszytko B, Orfao A, Schwartz LB, Sotlar K, Sperr WR, Triggiani M, Valenta R, Horny HP, Metcalfe DD.

Int Arch Allergy Immunol. 2012;157(3):215-25. doi: 10.1159/000328760. Epub 2011 Oct 27.

5.

Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.

Picard M, Giavina-Bianchi P, Mezzano V, Castells M.

Clin Ther. 2013 May;35(5):548-62. doi: 10.1016/j.clinthera.2013.04.001. Epub 2013 May 1. Review.

PMID:
23642289
6.

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Valent P, Escribano L, Broesby-Olsen S, Hartmann K, Grattan C, Brockow K, Niedoszytko M, Nedoszytko B, Oude Elberink JN, Kristensen T, Butterfield JH, Triggiani M, Alvarez-Twose I, Reiter A, Sperr WR, Sotlar K, Yavuz S, Kluin-Nelemans HC, Hermine O, Radia D, van Doormaal JJ, Gotlib J, Orfao A, Siebenhaar F, Schwartz LB, Castells M, Maurer M, Horny HP, Akin C, Metcalfe DD, Arock M; European Competence Network on Mastocytosis.

Allergy. 2014 Oct;69(10):1267-74. doi: 10.1111/all.12436. Epub 2014 May 19.

PMID:
24836395
7.

Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.

Ravi A, Butterfield J, Weiler CR.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):775-8. doi: 10.1016/j.jaip.2014.06.011. Epub 2014 Nov 6.

PMID:
25439370
8.

Evaluation of mast cell activation syndromes: impact of pathology and immunohistology.

Horny HP, Sotlar K, Valent P.

Int Arch Allergy Immunol. 2012;159(1):1-5. doi: 10.1159/000336374. Epub 2012 Apr 27. Review.

PMID:
22555026
9.

Mast Cell Activation Syndrome.

Frieri M.

Clin Rev Allergy Immunol. 2018 Jun;54(3):353-365. doi: 10.1007/s12016-015-8487-6. Review.

PMID:
25944644
10.

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.

Valent P, Bonadonna P, Hartmann K, Broesby-Olsen S, Brockow K, Butterfield JH, Triggiani M, Lyons JJ, Oude Elberink JNG, Arock M, Metcalfe DD, Akin C.

Int Arch Allergy Immunol. 2019;180(1):44-51. doi: 10.1159/000501079. Epub 2019 Jun 28. Review.

11.

Hymenoptera Allergy and Mast Cell Activation Syndromes.

Bonadonna P, Bonifacio M, Lombardo C, Zanotti R.

Curr Allergy Asthma Rep. 2016 Jan;16(1):5. doi: 10.1007/s11882-015-0582-5. Review.

PMID:
26714690
12.

Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis.

Weiler CR.

J Allergy Clin Immunol Pract. 2019 Aug 27. pii: S2213-2198(19)30729-9. doi: 10.1016/j.jaip.2019.08.022. [Epub ahead of print]

PMID:
31470118
13.

Mast cell activation syndrome: a review.

Frieri M, Patel R, Celestin J.

Curr Allergy Asthma Rep. 2013 Feb;13(1):27-32. doi: 10.1007/s11882-012-0322-z. Review.

PMID:
23179866
14.

Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.

Castells M, Butterfield J.

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1097-1106. doi: 10.1016/j.jaip.2019.02.002. Review.

PMID:
30961835
15.

Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders.

Valent P.

Clin Exp Allergy. 2014 Jul;44(7):914-20. doi: 10.1111/cea.12318. Review.

16.

Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).

Valent P, Aberer E, Beham-Schmid C, Fellinger C, Fuchs W, Gleixner KV, Greul R, Hadzijusufovic E, Hoermann G, Sperr WR, Wimazal F, Wöhrl S, Zahel B, Pehamberger H.

Am J Blood Res. 2013 May 5;3(2):174-80. Print 2013.

17.

Highly sensitive assays are mandatory for the differential diagnosis of patients presenting with symptoms of mast cell activation: diagnostic work-up of 38 patients.

Van den Poel B, Kochuyt AM, Del Biondo E, Dewaele B, Lierman E, Tousseyn T, de Hertogh G, Vandenberghe P, Boeckx N.

Acta Clin Belg. 2017 Apr;72(2):123-129. doi: 10.1080/17843286.2017.1293312. Epub 2017 Mar 6.

PMID:
28262030
18.

Successful treatment of mast cell activation syndrome with sunitinib.

Afrin LB, Cichocki FM, Patel K, Molderings GJ.

Eur J Haematol. 2015 Dec;95(6):595-7. doi: 10.1111/ejh.12606. Epub 2015 Jun 25.

PMID:
26072665
19.

Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.

Altmüller J, Haenisch B, Kawalia A, Menzen M, Nöthen MM, Fier H, Molderings GJ.

Immunogenetics. 2017 Jun;69(6):359-369. doi: 10.1007/s00251-017-0981-y. Epub 2017 Apr 6.

PMID:
28386644
20.

Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.

Valent P, Akin C, Gleixner KV, Sperr WR, Reiter A, Arock M, Triggiani M.

Int J Mol Sci. 2019 Jun 18;20(12). pii: E2976. doi: 10.3390/ijms20122976. Review.

Supplemental Content

Support Center